These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

997 related items for PubMed ID: 24327265

  • 21. Simvastatin in nephrotic syndrome. Simvastatin in Nephrotic Syndrome Study Group.
    Olbricht CJ, Wanner C, Thiery J, Basten A.
    Kidney Int Suppl; 1999 Jul; 71():S113-6. PubMed ID: 10412752
    [Abstract] [Full Text] [Related]

  • 22. Fluvastatin for lowering lipids.
    Adams SP, Sekhon SS, Tsang M, Wright JM.
    Cochrane Database Syst Rev; 2018 Mar 06; 3(3):CD012282. PubMed ID: 29508377
    [Abstract] [Full Text] [Related]

  • 23. Pentoxifylline for diabetic kidney disease.
    Shan D, Wu HM, Yuan QY, Li J, Zhou RL, Liu GJ.
    Cochrane Database Syst Rev; 2012 Feb 15; (2):CD006800. PubMed ID: 22336824
    [Abstract] [Full Text] [Related]

  • 24. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).
    Hahn D, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2015 Aug 07; 2015(8):CD005128. PubMed ID: 26258874
    [Abstract] [Full Text] [Related]

  • 25. Thyroid hormones for acute kidney injury.
    Nigwekar SU, Strippoli GF, Navaneethan SD.
    Cochrane Database Syst Rev; 2013 Jan 31; (1):CD006740. PubMed ID: 23440810
    [Abstract] [Full Text] [Related]

  • 26. Platelet-rich therapies for musculoskeletal soft tissue injuries.
    Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC.
    Cochrane Database Syst Rev; 2013 Dec 23; (12):CD010071. PubMed ID: 24363098
    [Abstract] [Full Text] [Related]

  • 27. Cerivastatin for lowering lipids.
    Adams SP, Tiellet N, Alaeiilkhchi N, Wright JM.
    Cochrane Database Syst Rev; 2020 Jan 25; 1(1):CD012501. PubMed ID: 31981471
    [Abstract] [Full Text] [Related]

  • 28. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P.
    Am J Cardiovasc Drugs; 2006 Jan 25; 6(3):177-88. PubMed ID: 16780391
    [Abstract] [Full Text] [Related]

  • 29. Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.
    Hahn D, Cody JD, Hodson EM.
    Cochrane Database Syst Rev; 2014 May 28; 2014(5):CD003895. PubMed ID: 24872328
    [Abstract] [Full Text] [Related]

  • 30. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.
    Cochrane Database Syst Rev; 2015 Jan 11; 1():CD008170. PubMed ID: 25577154
    [Abstract] [Full Text] [Related]

  • 31. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
    Sanders RD, Nicholson A, Lewis SR, Smith AF, Alderson P.
    Cochrane Database Syst Rev; 2013 Jul 03; 2013(7):CD009971. PubMed ID: 23824754
    [Abstract] [Full Text] [Related]

  • 32. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ, Watson KE, Talbert RL.
    J Manag Care Pharm; 2008 Oct 03; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [Abstract] [Full Text] [Related]

  • 33. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome.
    Feng M, Yuan W, Zhang R, Fu P, Wu T.
    Cochrane Database Syst Rev; 2013 Jun 05; 2013(6):CD006335. PubMed ID: 23740567
    [Abstract] [Full Text] [Related]

  • 34. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
    Sigurdsson G, Haraldsdottir SO, Melberg TH, Tikkanen MJ, Miettinen TE, Kristianson KJ.
    Acta Cardiol; 1998 Jun 05; 53(1):7-14. PubMed ID: 9638964
    [Abstract] [Full Text] [Related]

  • 35. Fibrates for secondary prevention of cardiovascular disease and stroke.
    Wang D, Liu B, Tao W, Hao Z, Liu M.
    Cochrane Database Syst Rev; 2015 Oct 25; 2015(10):CD009580. PubMed ID: 26497361
    [Abstract] [Full Text] [Related]

  • 36. Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
    Tenenbaum A, Fisman EZ, Motro M, Adler Y.
    Adv Cardiol; 2008 Oct 25; 45():127-153. PubMed ID: 18230960
    [Abstract] [Full Text] [Related]

  • 37. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y, Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, Braun N, Perna A.
    Cochrane Database Syst Rev; 2014 Oct 16; 2014(10):CD004293. PubMed ID: 25318831
    [Abstract] [Full Text] [Related]

  • 38. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2010 Nov 10; (11):CD003594. PubMed ID: 21069676
    [Abstract] [Full Text] [Related]

  • 39. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH, Lethaby A.
    Cochrane Database Syst Rev; 2013 Nov 15; (11):CD010241. PubMed ID: 24234875
    [Abstract] [Full Text] [Related]

  • 40. Vitamin B and its derivatives for diabetic kidney disease.
    Raval AD, Thakker D, Rangoonwala AN, Gor D, Walia R.
    Cochrane Database Syst Rev; 2015 Jan 12; 1(1):CD009403. PubMed ID: 25579852
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.